Marvel Biosciences Corp.

C$0.12As of Sun 8 Nov 2026, 12:00 UTC
TSXV:MRVLHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR (12.32%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.37
PE TTM —
TSR TTM (45.45%)
Mkt cap C$8.856M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.152
26.64%
(58.72%)
Buy 10|11|8|3|2
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
19.26%
15.95%
23.07%
25.73%
Revenue$M
0.819
0.797
0.835
0.828
3.99%
1.04%
0.76%
2.77%
Peers (US$6.268M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.644
(0.122)
(0.114)
EBIT/Intx
0.780
0.262
0.190
Own earn%
(146.59)
(2.38)
10.59
Sh yield%
24.69
18.45
15.85
Owners
Insiders/Inst%
1.04
22.43
Short interest%
1.57
SBC / revenue%
2.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–16
$1 testx
0.0
Incr. ROIC%
4